drugset / Trial / NCT00746954
Buspirone as a Potential Treatment for Recurrent Central Apnea
Phase 3
Terminated
8 enrolled
VA Office of Research and Development
University Hospitals Cleveland Medical Center · collab
RandomizedCrossoverTriple-blindBasic science
Summary
The purpose of this study is to determine whether buspirone compared to acetazolamide and to placebo will reduce the number and/or severity of breathing pauses during sleep that occur in some patients with Heart Failure.
Timeline
- Start
- 2008-09
- Primary completion
- 2011-09
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetazolamide | Small molecule | 250 mg | — |
| Subject | Buspirone | Small molecule | 20 mg | — |